Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
5.59
+0.07 (1.27%)
At close: Apr 28, 2026, 4:00 PM EDT
5.59
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Aardvark Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 13.79 | 5.31 | 2.17 | 2.7 |
| Research & Development | 48.94 | 17.36 | 4.48 | 7.17 |
| Operating Expenses | 62.73 | 22.79 | 7.42 | 10.36 |
| Operating Income | -62.73 | -22.79 | -7.42 | -10.36 |
| Interest & Investment Income | 5.14 | 2.41 | 1.42 | 0.12 |
| EBT Excluding Unusual Items | -57.59 | -20.37 | -5.99 | -10.24 |
| Gain (Loss) on Sale of Investments | -0.01 | -0.22 | -1.22 | -2.32 |
| Asset Writedown | - | - | - | -1 |
| Pretax Income | -57.59 | -20.59 | -7.21 | -13.56 |
| Net Income | -57.59 | -20.59 | -7.21 | -13.56 |
| Net Income to Common | -57.59 | -20.59 | -7.21 | -13.56 |
| Shares Outstanding (Basic) | 20 | 4 | 4 | 4 |
| Shares Outstanding (Diluted) | 20 | 4 | 4 | 4 |
| Shares Change (YoY) | 391.06% | 0.90% | 1.78% | - |
| EPS (Basic) | -2.93 | -5.15 | -1.82 | -3.49 |
| EPS (Diluted) | -2.93 | -5.15 | -1.82 | -3.49 |
| Free Cash Flow | -54.27 | -18.2 | -5.82 | -10.54 |
| Free Cash Flow Per Share | -2.77 | -4.55 | -1.47 | -2.71 |
| EBITDA | -62.69 | -22.77 | - | - |
| D&A For EBITDA | 0.04 | 0.02 | - | - |
| EBIT | -62.73 | -22.79 | -7.42 | -10.36 |
Source: S&P Capital IQ. Standard template.
Financial Sources.